Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2023 年第 2 季持倉
持倉截至 2023/6/30，2023/8/21 申報。只含多頭部位，變化是跟 2023 年第 1 季比股數。
- 持股檔數
- 62
- 較 2023 年第 1 季 −1
- 總值
- $2.54 億
- 較 2023 年第 1 季 −$612.2 萬 (−2.4%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 92,500 | $2,137 萬 | 8.4% | −500−0.5% | 減碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 550,000 | $1,748 萬 | 6.9% | +170,000+44.7% | 加碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 211,608 | $1,452 萬 | 5.7% | +98,384+86.9% | 加碼 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 321,017 | $1,233 萬 | 4.9% | −655,004−67.1% | 減碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,600,000 | $1,205 萬 | 4.7% | +1,600,000 | 新進 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 201,887 | $1,157 萬 | 4.6% | +66,024+48.6% | 加碼 | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 1,050,118 | $1,150 萬 | 4.5% | −33,000−3.0% | 減碼 | 歷史 |
| BIIBBiogen Inc. | COM | 40,000 | $1,139 萬 | 4.5% | +40,000 | 新進 | 歷史 |
| KURAKura Oncology, Inc. | COM | 910,317 | $963.1 萬 | 3.8% | +553,030+154.8% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 447,667 | $946.4 萬 | 3.7% | −5,154−1.1% | 減碼 | 歷史 |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $945.3 萬 | 3.7% | – | – | – |
| ACLXArcellx, Inc. | COMMON STOCK | 226,275 | $715.5 萬 | 2.8% | +23,441+11.6% | 加碼 | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 100,000 | $682.8 萬 | 2.7% | +100,000 | 新進 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 900,723 | $557.5 萬 | 2.2% | +216,596+31.7% | 加碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 650,875 | $542.2 萬 | 2.1% | +121,506+23.0% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 57,760 | $515.5 萬 | 2.0% | +17,760+44.4% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 260,000 | $493.2 萬 | 1.9% | +260,000 | 新進 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 300,000 | $486.3 萬 | 1.9% | −322,249−51.8% | 減碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 60,000 | $429.4 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 751,796 | $418.8 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 125,148 | $408.2 萬 | 1.6% | −96,315−43.5% | 減碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 1,589,017 | $378.2 萬 | 1.5% | +1,589,017 | 新進 | 歷史 |
| IMTXImmatics N.V. | SHS | 300,000 | $346.2 萬 | 1.4% | +300,000 | 新進 | 歷史 |
| Esperion Therapeutics Inc Ne29664WAB1 | NOTE 4.000%11/1 | – | $344.1 萬 | 1.4% | – | – | – |
| SWTXSpringWorks Therapeutics, Inc. | COM | 130,000 | $340.9 萬 | 1.3% | +130,000 | 新進 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 100,696 | $330.3 萬 | 1.3% | −159,312−61.3% | 減碼 | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 29,105 | $296.8 萬 | 1.2% | +29,105 | 新進 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 87,031 | $295.3 萬 | 1.2% | +37,031+74.1% | 加碼 | 歷史 |
| KYNBKyntra Bio, Inc. | COM | 983,300 | $265.5 萬 | 1.0% | +983,300 | 新進 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 60,376 | $232.4 萬 | 0.9% | −29,624−32.9% | 減碼 | 歷史 |
| THRXTheseus Pharmaceuticals, Inc. | COM | 240,244 | $224.1 萬 | 0.9% | +142,023+144.6% | 加碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM | 4,900,000 | $220.7 萬 | 0.9% | +4,900,000 | 新進 | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 1,492,771 | $194.1 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 800,676 | $182.6 萬 | 0.7% | +150,676+23.2% | 加碼 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 125,000 | $161.4 萬 | 0.6% | +125,000 | 新進 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 178,292 | $160.5 萬 | 0.6% | −30,000−14.4% | 減碼 | 歷史 |
| Intrexon Corp46122TAA0 | NOTE 3.500% 7/0 | – | $150.7 萬 | 0.6% | – | – | – |
| ADCTADC Therapeutics SA | SHS | 600,000 | $129.0 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 187,675 | $128.4 萬 | 0.5% | +187,675 | 新進 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 150,000 | $125.8 萬 | 0.5% | +150,000 | 新進 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 118,891 | $122.2 萬 | 0.5% | −129,000−52.0% | 減碼 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 100,000 | $118.9 萬 | 0.5% | +100,000 | 新進 | 歷史 |
| IFRXInflaRx N.V. | COM | 240,200 | $107.1 萬 | 0.4% | +240,200 | 新進 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 62,500 | $106.6 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 100,000 | $99.9 萬 | 0.4% | −50,000−33.3% | 減碼 | 歷史 |
| BCABBioAtla, Inc. | COM | 325,000 | $97.5 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 10,000 | $91.1 萬 | 0.4% | −25,000−71.4% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 12,500 | $89.8 萬 | 0.4% | +12,500 | 新進 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 300,068 | $85.5 萬 | 0.3% | +100,686+50.5% | 加碼 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 30,000 | $77.6 萬 | 0.3% | −65,000−68.4% | 減碼 | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 202,349 | $71.4 萬 | 0.3% | +25,000+14.1% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 13,923 | $69.5 萬 | 0.3% | −48,300−77.6% | 減碼 | 歷史 |
| JSPRJasper Therapeutics, Inc. | COM | 476,948 | $65.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $63.3 萬 | 0.2% | 00.0% | 不變 | – |
| TRMLTourmaline Bio, Inc. | COM | 200,000 | $60.8 萬 | 0.2% | +200,000 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 35,133 | $60.4 萬 | 0.2% | −284,867−89.0% | 減碼 | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 20,000 | $49.1 萬 | 0.2% | +20,000 | 新進 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 250,000 | $45.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NLS Pharmaceutics LtdH57830103 | SHS | 400,000 | $44.0 萬 | 0.2% | +55,911+16.2% | 加碼 | – |
| CNTXContext Therapeutics Inc. | COM | 267,574 | $42.8 萬 | 0.2% | +267,574 | 新進 | 歷史 |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 37,000 | $7.73 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $1.39 萬 | <0.1% | 00.0% | 不變 | – |
選擇權（6 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2023 年第 1 季之後清倉（20 檔）
2023 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 1 季股數 | 2023 年第 1 季市值 | 2023 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| RXDXPrometheus Biosciences, Inc. | COM | 150,000 | $1,610 萬 | 6.2% | 歷史 |
| MRKMerck & Co., Inc. | Stock | 120,000 | $1,277 萬 | 4.9% | 歷史 |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $712.1 萬 | 2.7% | – |
| Bellus Health Inc New07987C204 | COM NEW | 881,329 | $634.6 萬 | 2.4% | – |
| SGENSeagen Inc. | COM | 20,000 | $404.9 萬 | 1.6% | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 10,750 | $400.5 萬 | 1.5% | 歷史 |
| ETNB89bio, Inc. | COM | 200,000 | $304.6 萬 | 1.2% | 歷史 |
| LNTHLantheus Holdings, Inc. | Stock | 30,244 | $249.7 萬 | 1.0% | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 25,000 | $243.1 萬 | 0.9% | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 12,500 | $227.1 萬 | 0.9% | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 20,000 | $218.3 萬 | 0.8% | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 460,979 | $179.3 萬 | 0.7% | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 143,064 | $154.4 萬 | 0.6% | 歷史 |
| NARIInari Medical, Inc. | Stock | 20,000 | $123.5 萬 | 0.5% | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 149,586 | $108.7 萬 | 0.4% | 歷史 |
| FHTXFoghorn Therapeutics Inc. | COM | 136,771 | $84.8 萬 | 0.3% | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 100,000 | $73.8 萬 | 0.3% | 歷史 |
| Pieris Pharmaceuticals Inc720795103 | COM | 306,950 | $30.0 萬 | 0.1% | – |
| SCLXWScilex Holding Co | *W EXP 11/10/202 | 18,099 | $1.90 萬 | <0.1% | 歷史 |
| SCLXScilex Holding Co | COM | 463 | $3,797 | <0.1% | 歷史 |